Brain-Cognition Associations in Older Patients With Remitted Major Depressive Disorder or Mild Cognitive Impairment: A Multivariate Analysis of Gray and White Matter Integrity
- PMID: 37271418
- DOI: 10.1016/j.biopsych.2023.05.018
Brain-Cognition Associations in Older Patients With Remitted Major Depressive Disorder or Mild Cognitive Impairment: A Multivariate Analysis of Gray and White Matter Integrity
Abstract
Background: Almost half of older patients with major depressive disorder (MDD) present with cognitive impairment, and one-third meet diagnostic criteria for mild cognitive impairment (MCI). However, mechanisms linking MDD and MCI remain unclear. We investigated multivariate associations between brain structural alterations and cognition in 3 groups of older patients at risk for dementia, remitted MDD (rMDD), MCI, and rMDD+MCI, as well as cognitively healthy nondepressed control participants.
Methods: We analyzed magnetic resonance imaging data and cognitive domain scores in participants from the PACt-MD (Prevention of Alzheimer's Disease With Cognitive Remediation Plus Transcranial Direct Current Stimulation in Mild Cognitive Impairment and Depression) study. Following quality control, we measured cortical thickness and subcortical volumes of selected regions from 283 T1-weighted scans and fractional anisotropy of white matter tracts from 226 diffusion-weighted scans. We assessed brain-cognition associations using partial least squares regressions in the whole sample and in each subgroup.
Results: In the entire sample, atrophy in the medial temporal lobe and subregions of the motor and prefrontal cortex was associated with deficits in verbal and visuospatial memory, language skills, and, to a lesser extent, processing speed (p < .0001; multivariate r = 0.30, 0.34, 0.26, and 0.18, respectively). Widespread reduced white matter integrity was associated with deficits in executive functioning, working memory, and processing speed (p = .008; multivariate r = 0.21, 0.26, 0.35, respectively). Overall, associations remained significant in the MCI and rMDD+MCI groups, but not the rMDD or healthy control groups.
Conclusions: We confirm findings of brain-cognition associations previously reported in MCI and extend them to rMDD+MCI, but similar associations in rMDD are not supported. Early-onset and treated MDD might not contribute to structural alterations associated with cognitive impairment.
Trial registration: ClinicalTrials.gov NCT02386670.
Keywords: Cognition; Depression; Geriatric; Magnetic resonance imaging; Mild cognitive impairment; Neuroimaging.
Copyright © 2023 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Heterogeneity of Cognition in Older Adults with Remitted Major Depressive Disorder: A Latent Profile Analysis.Am J Geriatr Psychiatry. 2024 Jul;32(7):867-878. doi: 10.1016/j.jagp.2024.01.225. Epub 2024 Feb 2. Am J Geriatr Psychiatry. 2024. PMID: 38403532
-
Slowing Cognitive Decline in Major Depressive Disorder and Mild Cognitive Impairment: A Randomized Clinical Trial.JAMA Psychiatry. 2025 Jan 1;82(1):12-21. doi: 10.1001/jamapsychiatry.2024.3241. JAMA Psychiatry. 2025. PMID: 39476073 Clinical Trial.
-
Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.Brain Topogr. 2019 Jan;32(1):142-160. doi: 10.1007/s10548-018-0675-2. Epub 2018 Sep 11. Brain Topogr. 2019. PMID: 30206799
-
Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.Cochrane Database Syst Rev. 2020 Mar 2;3(3):CD009628. doi: 10.1002/14651858.CD009628.pub2. Cochrane Database Syst Rev. 2020. PMID: 32119112 Free PMC article.
-
Brain-cognition relationships in late-life depression: a systematic review of structural magnetic resonance imaging studies.Transl Psychiatry. 2023 Aug 19;13(1):284. doi: 10.1038/s41398-023-02584-2. Transl Psychiatry. 2023. PMID: 37598228 Free PMC article.
Cited by
-
A bibliometric analysis of research on dementia comorbid with depression from 2005 to 2024.Front Neurosci. 2025 Feb 4;19:1508662. doi: 10.3389/fnins.2025.1508662. eCollection 2025. Front Neurosci. 2025. PMID: 39981405 Free PMC article.
-
Proteogenomic signature of Alzheimer's disease and related dementia risk in individuals with major depressive disorder.Nat Ment Health. 2025 Aug;3(8):879-888. doi: 10.1038/s44220-025-00460-0. Epub 2025 Jul 14. Nat Ment Health. 2025. PMID: 40823340 Free PMC article.
-
Depressive symptom mediates the association between the number of chronic diseases and cognitive impairment: a multi-center cross-sectional study based on community older adults.Front Psychiatry. 2024 Jul 17;15:1404229. doi: 10.3389/fpsyt.2024.1404229. eCollection 2024. Front Psychiatry. 2024. PMID: 39086730 Free PMC article.
-
Generalizability of Treatment Outcome Prediction Across Antidepressant Treatment Trials in Depression.JAMA Netw Open. 2025 Mar 3;8(3):e251310. doi: 10.1001/jamanetworkopen.2025.1310. JAMA Netw Open. 2025. PMID: 40111362 Free PMC article. Clinical Trial.
-
Proteogenomic signature of risk of Alzheimer's disease and related dementia risk in individuals with a history of major depression disorder.medRxiv [Preprint]. 2024 Sep 12:2024.09.11.24313493. doi: 10.1101/2024.09.11.24313493. medRxiv. 2024. Update in: Nat Ment Health. 2025 Aug;3(8):879-888. doi: 10.1038/s44220-025-00460-0. PMID: 39314945 Free PMC article. Updated. Preprint.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous